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3 ½ year old boy with multicystic area in liver extending upto
skin. His Echinococcocus titer became positive.
Diagnosis Hydatid Cyst
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Combating Childhood Pneumonia and Diarrhea at Community Level: Potential of m Health to
improve interaction among health workers
Pneumonia and diarrhea are the leading causes of mortality and
morbidity among children under five. Together, these two early
childhood infections lead to one-fifth of under-five mortality
across the globe.1,2  Major proportion of these deaths occur in
the resource constrained settings of developing and
underdeveloped world.3
In Pakistan, approximately 91,000 child deaths are attributable
to pneumonia and 53,000 to diarrhea annually thus contributing
to 46% of overall under-five mortality. Due to suboptimal
performance of country’s health system the target of improving
child survival by bringing down deaths from pneumonia to
fewer than three children per 1,000 live births and from diarrhea
to less than one in 1,000 remains a labor intensive challenge.3
Pakistan has a three tiered public health system consisting of
primary, secondary and tertiary health care facilities. Covering
60% of rural population and working through 130,000 Lady
Health Workers (LHWs), the Lady Health Worker’s Program
(LHW-P) represents the outreach community based component
of this system. It is meant to work in coordination with the
primary care facilities: basic health units (BHUs) and rural
health centers (RHCs). Lady Health Supervisors (LHSs) are
responsible for on-going supervision and mentoring of LHWs.
Community Case Management (CCM) for childhood diarrhea
and pneumonia constitutes an important component of the
LHW-P. Ironically, LHWs are not well integrated into the
broader public health sector and cases referred by LHWs receive
little priority at facility level. It is therefore not surprising that
there have been negligible improvements in the coverage of
essential interventions. According to an estimate, only 38%
cases with diarrhea received ORS and antibiotics were
administered to 41% pneumonia patients.4
The fourth evaluation of the LHW-P has indicated that weak
supervision of LHWs by LHS is an important determinant of
the stagnant under five mortality.5  One of the important reasons
identified for this feeble supervision is the lack of coordination
and interaction between LHWs and their LHSs. Insufficient
interaction among health workers is evidenced by the fact that
40% of the LHSs do not conduct the required household
supervisory visits, only 28% LHWs were informed about their
performance scores in writing during a supervisory meeting at
the facility while 61% LHWs did not receive any type of
feedback (verbal or written) from their supervisors.  Lack of
transport, refresher training,regular salary and accessibility to
the assigned areas were some of the barriers preventing LHSs
to serve as effective supervisors.
Project NIGRAAN (2013-2015), a cluster randomized
implementation research project addressed this coordination
and communication gap between LHWs and LHSs in the
presence of existing logistic barriers. NIGRAAN used simple
cell phones (<30 US $ per unit cost) for enhancing timely case
reporting by LHWs and supervisory follow up visits by LHSs.
Short Message Service (SMS)  was utilized to track cases of
childhood diarrhea and pneumonia within the existing
Management Information System  of LHW-P in District Badin,
Sind. 34 LHSs and 170 LHWs were enrolled. LHSs were given
cell phones for real-time communication with LHWs while
LHWs were provided a minimal monthly communication
allowance to purchase SIM cards. LHWs upon case identification
relayed information and arranged appropriate follow up visits
with LHSs via mobile. Total 6128 cases were tracked (diarrhea:
3058; pneumonia: 3070). Between the first and final quarter of
surveillance, LHW to LHS case reporting via SMS improved
from 43% to 98%. Almost all cases were reported by LHWs
to LHSs within 24 hours of identification. LHSs followed up
more than 60% of reported cases at the household and also
provided LHWs written feedback.The specific outcome of the
illness was tracked via cell phones 72 hours later; 47% cases
were found to be recovering with private treatment, 26% with
government facility treatment and 3% with LHW treatment.
ORS was provided to 23% diarrhea and antibiotics to 2%
pneumonia cases by LHWs. This may be attributable to shortage
of supplies with LHW-P. Referral rates to other facilities were
high especially for cases with pneumonia.
According to a report, mobile technology has already contributed
to promote health care services in India, Bangladesh and
Botswana.6 Mobile health (m health) based interventions enhance
efficiency of service delivery ensuring timely feedback and
supervision by the health managers through effective
communication. The same report shows that in Uganda and
Rwanda, m Health improved child health by facilitating remote
diagnosis and treatment. In Pakistan, NIGRAAN is one of the
first studies to demonstrate the possibility of obtaining child
health related data from marginalized rural areas in real time
using a m health intervention. It has shown that m Health is
technically feasible, usable and acceptable by frontline health
workers.The study has also demonstrated that using m health
LHW-P has the potential to enhance interaction and coordination
between LHWs and LHS, identify cases, report, manage and
refer them to the next level of care.
With this growing body of evidence it is time to invest in wide
scale deployment of mobile technology in developing countries
where access to good quality health care remains an unachievable
goal for the poor and marginalized. The LHW Programme in
Pakistan provides readily available health services at community
GUEST EDITORIAL
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door steps and thus offers a very good investment opportunity
to strengthen the fragile health system of Pakistan using m health.
Fauziah Rabbani, Aysha Zahidie, Kashif Sangrasi
Department of Community Health Sciences,
The Aga Khan University. Karachi
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ORIGINAL ARTICLE
Introduction
Paediatrics Cervical lymphadenopathy (CLAP) is one of the
most common and challenging presenting findings in outpatient
pediatrics. Most of them are bengining with a reactive process
(infectious or inflammatory) that usually self-resolving without
any sequels. Reactive hyperplasia is mostly because of bacterial,
viral or protozoal infections but  malignancies are always in the
list of differential diagnoses.1,2 Up to 40-60% of paediatrics
population has CLAP at some point in their life.3,4 Cervical lymph
nodes drain the head and neck region of the body. A thorough
history and physical examination is the key in understanding the
disease process and its likely differential diagnoses.5 A biopsy
is indicated if CLAP doesn’t respond to conventional antibacterials.
The purpose of this study is to determine the  common etiologies
identified after excisional cervical lymph node biopsy  in children
that did not respond to first line conventional antibacterial in
tuberculosis endemic setting.
Methods
We performed an audit of all cases of pediatric CLAP who
underwent excisional biopsy in the last 23 years (1988 to 2011)
at the Aga Khan University hospital, Karachi, Pakistan. Prior
approval was taken from our medical record audit committee.
Aga Khan University is a major tertiary care hospital in the
middle of the metropolitan city of Karachi. We included all
children who were aged 15 years or younger, and presented
with enlarged cervical lymph nodes which failed to regress
after appropriate antibacterial therapy, and were then referred
for an excisional biopsy to the pediatric surgeon during the
mentioned period. Cases were identified via two sources; i)
Hospital information management system (HIMS) by using
international classification of disease (ICD-9-CM) codes: – a)
Diseases; 785.6 (enlarged lymph nodes) b) Procedures; 40.21
(excision of deep cervical lymph nodes); 40.3 (regional lymph
node excision); 40.4 (radical excision of cervical lymph nodes),
and ii) hospital internal histopathology registry to confirm that
the procedure was performed in-hospital . Children with
excisional biopsies performed outside AKU  hospital were
excluded. Histopathological findings (benign or malignant)
was the outcome variable, while gender, age at presentations,
presenting complaint, single or multiple lymph node
involvement, bacterial cultures etc., were the independent
variables of the study. Data was analyzed by using statistical
package of social sciences (SPSS version 19.0) software.
Descriptive data analyses were done and the results are presented
Abstract
Paediatric cervical lymphadenopathy (CLAP) is a common
presentation in pediatric practice. A biopsy is indicated if it
fails to regress in size within 4-6 weeks after appropriate medical
therapy. We aim to report the frequency  of  the various causes
of lymphadenopathy in children as determined by histopathology.
Methods
This is a retrospective review of 170  children who underwent
excisional biopsy of the cervical lymph node from 1988-2011.
Data was extracted from the health information management
system. Data was collected on gender, histopathological findings,
and age at presentation. Bivariate analysis (by using
chi-square test) was used to identify any significant differences
between outcome categories (benign or malignant) with respect
to the independent variables. P-value and 95% confidence intervals
were calculated and p-values < 0.05 were considered significant.
Results
Persistent low grade fever with or without weight loss was the
commonest indication for biopsy. Histopathology showed
benign disease among 77% (n=131). Amongst the benign causes,
tuberculosis (n=55, 42%) was the most common  while
lymphoma (n=32, 19%) was the most common malignant cause
of CLAP.  Children older than 5 years of age were 1.6 times
more likely to have a malignant lesion with persistent CLAP
unresponsive to antibacterial therapy (p=0.17, 95% CI, 0.7–3.7).
Malignant lesions were 7.1 times more common time  males
(p=<0.001, 95% CI, 2.6–19.3) and 3.2 times more with multiple
enlarged CLAP (P=0.01, 95% CI, 1.2–8.8).
Conclusion
Benign diseases (reactive lymphadenopathy and tuberculosis)
remain the most common cause of persistent cervical
lymphadenopathy. However male gender, age> than 5 years
and multiple cervical lymph nodes should alert the physician
towards evaluation for more sinister diagnoses.
Key words
Persistent Cervical Lymphadenopathy, Paediatrics, Tuberculosis,
Lymphoma
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as means and standard deviation for continuous variables (i.e.,
age) and proportions for categorical variables (i.e., gender,
benign or malignant). Bivariate analysis (by using chi-square
test) was used to identify any significant differences between
outcome categories (benign or malignant) with respect to the
independent variables. P-value and 95% confidence intervals
were calculated and p-values < 0.05 were considered significant.
A total of 170 children with complete records were available
for the analysis. All the possible efforts were made to maintain
the confidentiality of patients.
Results
Out of 170 children, majority were male (n=98, 58%). Two
third (n=112, 66%) were older than 5 years of age. Most of the
children had multiple cervical region lymphadenopathy (n=122,
72%). Presenting complaints at the time of admission were
fever (n=165, 97%), enlarged cervical lymph nodes (n=129,
76%) and/or generalized lymphadenopathy (n=75, 44%). Other
presenting complaints includes undocumented weight loss and
discharging sinus . Histopathological diagnoses was consistent
with a non-specific inflammation in most of the cases (n=71,
42%). Overall histopathological finding were consistent with
benign diseases (n=131, 77%). Tuberculosis (n=55, 42%) was
the most common  diagnosis on histopathology. Lymphoma
was second most common diagnosis (n=32, 19%). Less common
diagnoses included leukemia (n=5, 3%), histiocytosis,
toxoplasmosis, metastatic disease, Sjögren's syndrome and
Rosai-Dorfman disease (Figure 1). Cultures were sent in only
61 (36%), where majority of them did not show any growth
(n=46, 75%). Streptococcus species (n=7), Staphylococcus
aureus (n=4) and Mycobacterium tuberculosis (n=4) were the
few organisms identified.
We divided our study subjects into two groups; the malignant,
that included lymphomas, leukemia’s and metastatic nodes and
the benign group that included all other diagnosis. Children
older than 5 years of age were 1.6 times more likely to have
malignant lesions  (p=0.17, 95% CI, 0.7–3.7). Malignancy was
7.1 times more common among males (p=<0.001, 95%  CI,
2.6–19.3) and 3.2 times more likely with multiple enlarged
CLAP (P=0.01, 95% CI, 1.2–8.8). (Table 1).
Discussion
Cervical lymphadenopathy is common in paediatric population.2
We found an that benign lesions, non-specific reactive lymph
node and tuberculosis were the commonest causes of CLAP.
However a small proportion of children were diagnosed  with
lymphoma. Male gender, age > 5 years of age and multiple
cervical lymph nodes increased the likelihood of malignancy.
Most cases of cervical lymphadenitis in children are self-limiting
and can safely be monitored for spontaneous resolution over
four to six weeks.2 In 40% to 80% of cases acute unilateral
lymphadenopathy is most commonly caused by streptococcal
or staphylococcal infections, while acute bilateral cervical
lymphadenopathy caused by upper respiratory tract viral
infections.  Supraclavicular or posterior cervical
lymphadenopathy carries a much higher risk for malignancies
than anterior cervical lymphadenopathy.
Incidence of palpable lymph nodes is 90% in children aged 4-
8 years.4  According to Larsson et al. approximately 38-45%
of otherwise healthy children have palpable lymph nodes.6
According to another survey, 44% of the children in a community
will have palpable nodes and about 64% of the sick children
in hospitals will have palpable lymph nodes. 68% of
lymphadenopathies are benign in children. More than 25% of
the malignant tumors in children occur in the head and neck
region and the cervical lymph nodes are the most common
sites. In particular, in children with chronic cervical
Jul - Sep 2015.  839
Fig 1. Spectrum of histopathological findings in the study population
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lymphadenopathy, it is of paramount importance to exclude
a neoplasm. Enlarged supraclavicular lymph nodes may be
the first sign of intra-abdominal malignancy. Failure of
regression after appropriate antibiotic therapy within 4-6
weeks is an indication for diagnostic excisional biopsy.1 If
there is any suspicion of malignancy or in cases of persistent
lymphadenopathy an excisional biopsy with microscopic
examination of the lymph node should be performed.7,8
Excisional biopsy is still the gold standard, because in children
fine-needle biopsy is difficult to perform and can be accepted
as accurate in positive findings only.9 The biopsy should be
done on the largest and the firmest node that is palpable, and
the node should be removed intact with the capsule.7,8,10 Such
a method is most useful in the diagnosis of lymphoma. If
there is a packet of nodes, extirpation of at least 2–3
neighboring lymph nodes is necessary for the suitable
histological diagnosis.5
When comparing these results with the international literature,
we found a higher rate of tuberculosis (32%) and malignancy
(19%) in our study population as compared to the other
studies.11,12  It may be because of the fact that tuberculosis is
very prevalent in our society because of third world country,
which is not the fact in most western countries. We have also
looked at the incidence of malignancy as compared to number
of lymph node. Literature is quite supportive of increase
incidence of malignancy with multiple lymphadenopathies.13
Histopathological and microbiological diagnosis is imperative
prior to start any treatment.
There are few limitations, this was  a retrospective study, low
rate of specimens sent to microbiology and low bacterial cultures
yield. It is single center study which needs further attention.
The association with males could be because of the differential
health seeking behaviour for male children and the high
frequency of malignancy seen could be because of selective
pattern of referrals for children with malignancies.  This may
have an impact on our results as we have found higher incidence
of malignancy in children age 5 years.
Conclusion
Fever with cervical lymphadenopathy is the most common
presentation.  Although non-specific inflammation is the most
common diagnosis but tuberculosis and malignancy are high
in children in our study. Trend of malignancy is seen more in
multiple enlarged cervical lymph nodes in older male children.
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Abstract
Introduction
Pneumococcal meningitis is a leading cause of morbidity and
mortality worldwide. Rising penicillin and ceftriaxone resistance
in different regions of world has led to the guideline
recommendation of adding vancomycin to ceftriaxone for
empirical treatment of pneumococcal meningitis. This study
aimed to determine penicillin and ceftriaxone resistance rates
in Streptococcus pneumoniae isolates causing meningitis in
Pakistan.
Methods
A prospective cross-sectional study was conducted from January
2011 to March 2014 at the Clinical Microbiology Laboratory
of Aga Khan University. Forty-six pneumococcal strains from
CSF and blood cultures were considered as meningeal strains
according to clinical presentation and included in this study
while duplicates were excluded. S. pneumoniae isolates were
identified on colony morphology and optochin sensitivity.
Minimum inhibitory concentrationof penicillin and ceftriaxone
were performed by E-test method and interpreted according to
CLSI.
Result
Out of 46 isolates 33% (n=15) were from patients younger than
5 years, 48%(n=22) between 5-65years while 19%(n=09) older
than 65 years. Twelve strains (26.09%) were found to be resistant
to penicillin; ceftriaxone and vancomycin resistance was not seen.
Conclusions
This study showed penicillin resistance to be high among the
S. pneumoniae causing meningitis, justifying the empiric use
of ceftriaxone. However, resistance to ceftriaxone was not seen,
suggesting that the addition of vancomycin in empiric therapy
is not required in cases that acquire meningitis locally and have
no history of travel.
Key Words
Meningitis, Streptococcus pneumoniae, penicillin resistance,
ceftriaxone, vancomycin.
Introduction
Pneumococcal disease is a major threat to global health. It is
a leading cause of severe infections such as pneumonia and
meningitis.1 According to World Health Organization, it is
estimated that 1.6 million people die every year from it and
majority of them are children especially in developing countries.1
The burden of pneumococcal meningitis is largely under-
investigated in Pakistan.2 Pneumococcal Global Burden of
Disease Study Team concluded that Pakistan, including six
other countries of Asia, has the highest number and proportion
of Streptococcus pneumoniae cases.3
Globally, there is a changing trend in the antibiotic susceptibility
pattern of S.pneumoniae responsible for invasive infections.4, 5
There is an increase in rate of resistance to various classes of
antibiotics especially β-lactams, which have traditionally been
an effective treatment.4 This makes the treatment more difficult
and costly. Resistance rates vary widely among different
geographic regions. Guideline for pneumococcal meningitis
recommends ceftriaxone and vancomycin as an empirical
treatment.6 Vancomycin is an expensive as well as toxic drug.
Its overuse may lead to resistance not only in Streptococcus
pneumoniae but also other commensal Enterococcus species
and Staphylococcus species etc. Moreover, availability of this
drug is limited in Pakistan. Resistance to penicillin, ceftriaxone
or any other 3rd generation cephalosporin among invasive isolates
of S.pneumoniae has not been documented yet in Pakistan.2
Moreover our neighbouring country India has reported just
1.3% penicillin resistance.7 Therefore there is urgent need to
analyse the penicillin and ceftriaxone susceptibility pattern in
invasive S.pneumoniae isolates so as to guide the physician for
empiric use of penicillin, ceftriaxone and vancomycin.
Methods
Study Design
A prospective cross-sectional study was conducted from January
2011 to March 2014 at the Clinical Microbiology Laboratory
of Aga Khan University. The Aga Khan Clinical laboratory
receives specimens from patients admitted to Aga Khan
University Hospital (AKUH), a tertiary care 700 bedded private
In-vitro Evaluation of Penicillin and Ceftriaxone resistance amongst Streptococcus pneumoniae isolates
causing meningitis, a cross sectional study at The Aga Khan University Hospital Clinical Laboratory,
Karachi, Pakistan
Haresh Kumar, Seema Irfan, Joveria Farooqui, Naima Fasih, Afia Zafar
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Corresponding Author: Haresh Kumar,
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setting. In addition, this laboratory receives samples from more
than 200 collection points spread all over the country. All
invasive strains of S. pneumoniae isolated from cerebrospinal
and blood were included. Duplicates were also excluded. In
case of isolation of S. pneumonia from both cerebrospinal fluid
(CSF) and blood of same patient, only CSF isolate was included
in the study. Patient’s demographic data as well as clinical
information including drug therapy was gathered via telephonic
communication with respective clinicians.
Microbiological Identification and Susceptibility Testing
Methods
Identification of S. pneumoniae was made using American
Society of Microbiology guidelines. Initial suspicion of organism
was made on the basis of centrally depressed colony morphology
and β-hemolysis, grams staining and catalase test. Final
identification was made by conventional tests such as optochin
and bile salt susceptibility.8, 9 To perform susceptibilities, 0.5
McFarland was made than sterile swab was squeezed to remove
the excessive fluid, lawn was made on Mueller-Hinton agar
with 5% sheep blood (SB-MHA), than E-test strip of penicillin
and ceftriaxone was placed over the lawn. Plates were incubated
for 24h. After 24h of incubation MICs were measured and
interpreted according to breakpoints provided by the Clinical
and Laboratory Standards Institute (CLSI) guideline and isolate
was categorized as sensitive (S), intermediate (I) or resistant
(R).10 As current CLSI MIC break points for penicillin and
ceftriaxone are different for meningeal and non-meningeal
isolates. For meningeal strains, penicillin MIC ≤0.06 µg/ml is
considered susceptible while MIC of 0.12 µg/ml is categorized
as resistant. Similarly for meningeal isolates ceftriaxone MIC
of ≤0.5 µg/ml, 1µg/ml and 2 µg/ml are defined as susceptible,
intermediate and resistant.
Data Analysis
Data was coded and entered into SPSS version 21.0 for statistical
analysis. Mean and standard deviation of the continuous variables
i.e. age, penicillin and ceftriaxone MICs were calculated.
Frequency and percentage of the categorical variables i.e. source
of specimen, antibiotic susceptibility categories were calculated.
Results
During the study period a total of 146 S. pneumoniae were
grown from blood and CSF. A total of 46 S. pneumoniae were
considered meningeal isolates. 42/46 patients belonged to
Karachi. Regarding age group of patients, 33% (n=15) belonged
to <5 years, 22 (48%) were between 5-65 years of age while
09(19%) were above 65 years of age.
Out of these 46, 27 isolates were from CSF and four of these
were from both CSF and blood. From these four cases only
CSF isolates were included in the analysis. Nineteen additional
isolates yielded from blood cultures were interpreted according
to meningeal break-points as clinical history was suggestive of
meningitis as shown in table 1.
Out of 46 meningeal strains 12(26.1%) isolates were found to
be resistant to penicillin while none were resistant to ceftriaxone
and vancomycin. Chloramphenicol resistance was found in 6
(14.3%) isolates.
Regarding penicillin and ceftriaxone minimum inhibitory
concentration, MIC50 and MIC90 was evaluated as shown in table 2.
Discussion
This study reveals penicillin and ceftriaxone susceptibility of
S.pneumoniae causing meningitis in Karachi. This data clearly
indicates that penicillin resistance is high (26%) in S.pneumoniae
causing meningitis, however, ceftriaxone resistance was not
detected in local isolates. Published data from different countries
reports variable prevalence of penicillin and ceftriaxone
resistance amongst S. pneumoniae. For example study from
South Africa reveals penicillin resistance in 33% of their invasive
strains11 while a centre in Baltimore, USA12 had reported 48.6%
penicillin resistant strains. On the other hand neighbouring countries
such as India and Bangladesh reported very low prevalence of
penicillin non-susceptible isolates in their studies.13-15 Regarding
ceftriaxone non-susceptibility, international data again shows
wide variation.16-18 In Pakistan surveillance data for susceptibility
of invasive S. pneumoniae isolates is not sufficient. In fact
current study comprised of highest number of meningitis causing
S. pneumoniae isolates that were analysed for susceptibility
pattern. A previous community based study evaluated 15 strains
of S. pneumoniae, from two major cities of Pakistan, Karachi
and Hyderabad; the resistance susceptibility of S. pneumoniae
to penicillin in that study was also 26%, consistent with our
findings.19 In addition we evaluated available antibiogram
published by different tertiary care hospitals of Karachi and
found very low percentage of penicillin resistance in S.
pneumoniae.20
Current international guidelines recommend empiric vancomycin
use along with ceftriaxone for the treatment of pneumococcal
meningitis. Out of 46, 12 isolates (26%) revealed resistance to
penicillin and justified the need of empiric ceftriaxone in cases
of suspected bacterial meningitis. However, as all of the
meningitis causing S. pneumoniae strains revealed ceftriaxone
Table 1: Distribution of Streptococcus pneumoniae isolates
in clinical specimens.
Meningeal isolates of Streptococcus pneumoniae 46 (%)
Cerebrospinal fluid 19 (41.3)
Cerebrospinal fluid and Blood 04 (8.7)
*Blood 23 (50)
*S. pneumoniae isolated only from blood but clinical
symptoms and signs were suggestive of meningitis
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MIC within susceptible range with MIC50 and MIC90 of 0.023,
0.094 µg/ml respectively. Therefore, our finding points out the
overuse of empiric vancomycin for S.pneumoniae meningitis.
Our data also shows that penicillin MIC90 for S. pneumoniae
isolates was 0.125µg/ml, which further supports sole use of
ceftriaxone in our setting. This is based on international treatment
guidelines21 which recommend sole ceftriaxone usage at
penicillin MIC of ≤1µg/ml. We suggest that resource limited
laboratories; instead of simultaneous performance of penicillin
and ceftriaxone MIC, can perform penicillin MIC first and if
it is ≤1µg/ml, then do not perform ceftriaxone MIC. In these
cases a comment can be released saying that low penicillin
MIC indicates susceptibility to ceftriaxone.
This study highlights the importance of use of blood culture
for the diagnosis of pneumococcal meningitis. Out of 46 cases,
blood culture was found positive in 58.6% cases which indicate
that in addition to CSF culture, blood culture should always be
requested in suspected cases of S. pneumoniae meningitis. In
addition, keeping in consideration the difficulty of drawing
CSF from very sick patient whom lumber puncture is
contraindicated, blood culture can be considered as a safe and
high-yield alternative.
In conclusion, penicillin resistance is found in one quarter of
S. pneumoniae causing meningitis justifying the empiric use of
ceftriaxone. However, resistance to ceftriaxone was not seen
in this study which suggests that the addition of vancomycin
in empiric therapy of pneumococcal meningitis is currently not
required in those patients who acquired meningitis locally and
have no history of travel. Continuous monitoring of antimicrobial
susceptibilities is required by clinical laboratories to find out
any emerging ceftriaxone resistance.
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Abstract
Background
Neonatal jaundice has long been recognized as a commonest
problem in neonate. Most of the time, it is benign. In young
infant’s bacterial urinary tract infection (UTI) can lead to serious
outcome. Clinical presentation of UTI in neonates has variable
spectrum ranging from asymptomatic to severe sepsis. We
performed this study to determine the incidence of neonatal
jaundice among sick neonates who developed UTI in a tertiary
care center.
Material & Method
We performed this cross-sectional study at neonatal intensive
care unit and neonatal high density unit (HDU) of pediatric
medicine of Liaquat National Hospital and Medical College
over a period of one year (January 2013 - December 2013).
The total sample size of our study was 173 neonates. Incidences
of UTI (on the basis of urine direct report and culture) as well
as most common organisms leading to UTI were recorded.
Results
Of the173 patients enrolled in the study, 82 (47%) were male
and 91(52%) were female. A total of 77 out of 173 (45%)
jaundiced neonates were diagnosed to have pyuria (based on
positive urine direct report), of those 30 (39%) patients had a
positive urine culture. The most common bacterial pathogen
isolated was E.coli (43%), followed by Klebsiella (27%),
Acinetobacter (13%), Proteus (10%) and Staphylococcus aureus
(7%) respectively. Moreover, only 25 (14%) neonates had
predominantly direct hyperbilirubinemia while the rest had
indirect hyperbilirubinemia (86%).
Conclusions
UTI may present with jaundice in neonates, thereforeany neonate
who presents with pathological jaundice should be investigated
for urinary tract infections.
Key Words
 Neonates, Urinary Tract Infection, Jaundice.
Introduction
Neonatal jaundice in most cases recognized as a benign problem
for long time.1 It is considered as common cause of newborn
admission in neonatal units incidence is 39.7/1000 live birth.2
During the first week of life 80% preterm and 60% term develop
visible jaundice.3, 4
In young infant urinary tract infection (UTI) is a serious bacterial
infection. Its incidence varies from 0.1 – 1% in neonates and
from 5% and 11% among febrile infants.5 In neonates, clinical
presentation of UTI is extremely variable ranging from
asymptomatic to severe sepsis.6 The first sign of UTI in
asymptomatic infants may be jaundice before other signs and
symptoms become obvious. Jaundice was found in 6.8%
neonates with urinary tract infection.7
Accumulation of unconjugated, nonpolar, lipid-soluble bilirubin
pigment in the skin lead to yellow color of jaundice.8 The
antioxidant nature of bilirubin is very protective and it is said
to protect the antioxidant deficient baby from oxygen toxicity
in the early neonatal life.9
Some cases of otherwise benign physiological jaundice may
have other diseases in combination. Variousresearches has been
done on the association of idiopathic hyperbilirubinemia and
bacterial infections, such as urinary tract infection (UTI).
Relation of coincidental UTI and hyperbilirubinemia is still
ambiguous. However, some theory proposed the idea of that
gram negative bacillus especially E.coli produces hepatotoxins
which leads to hemolysis of RBCs causing indirect
hyperbillirubinemia. Though direct hyperbillirubenemia with
UTI may be due to cholestasis, for which exact etiology is still
unknown.7
There is currently no recommendation for UTI evaluation
among neonates with neonatal hyperbilirubinemia. Urinalysis
and a urinary culture are only recommended under some certain
conditions, such as infants who have an elevated conjugated
bilirubin, and infant readmitted for phototherapy or exchange
transfusion.8 However, the coincidental occurrence of UTI with
indirect hyperbilirubinemia in our clinical practice supported
by some studies prompted us to undergo this research so as to
emphasize upon routine investigation of icteric babies for UTI.
Material & Methods
This was a cross-sectional study conducted in the NICU and
HDU of Department of Pediatric Medicine of Liaquat National
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Hospital and Medical College over a period of one year, from
January 2013 till December 2013.The inclusion criteria included
all the neonates (age = 28 days) admitted in NICU with complain
of neonatal jaundice irrespective of gestational age and weight.
The exclusion criteria included all the babies (age > 28 days)
and all those who are admitted with complain other than jaundice.
A questionnaire was made which was kept in Neonatal Intensive
Care Unit (NICU) and HDU.It was filled by the duty doctor
and was then checked by the researcher. Demographic and
historic factors such as gender, gestational age, body weight,
mode of feeding, circumcision status and onset of jaundice
were recorded. Blood samples were taken from all the cases
and their complete  blood count with reticulocyte count ,serum
bilirubin level (total and direct), coomb’s test, G6PD level,
maternal and neonatal blood group were evaluated.
In addition, urine analysis and urine cultures were performed.
Furthermore, the enrolled patients were divided intogroups,
with and without pyuria according to the results of urinalysis
reports.
Definite pyuria was defined as leukocyte count of 20/HPF.
Cases with UTI were defined as the presence of any number
of colony forming units (CFU)/mL of pathogens obtained by
supra-pubic puncture collection, more than 10,000 CFU/mL
obtained by bladder catheterization, or more than 100,000
CFU/mL of pathogens obtained by urinary bag collection.
Otherwise, the patients would be grouped into the no UTI group.
After initial evaluation and treatment of the infants ultrasound
were requested to all cases with UTI. The data was analyzed
using SPSS software.
Significant Values:-Descriptive data were reported as mean ±
SD. Statistical significance was defined as P value < 0.05.
Results
Of the173 patients enrolled in the study, 82 (47.4%) were male
and 91(52.6%) were female. All males were uncircumcised.
The mean gestational age of all neonates was 38.6 weeks range
(37-41weeks) and mean body weight was 3.32 kg range (2.61-
 4.25kg).A total of 77 out of 173 (44.5%) jaundiced neonates
were diagnosed to have pyuria (based on positive urinalysis).
Table 1 shows that 77 babies had pyuria out of which 30 patients
had a positive urine culture. More females (61%) than males
(38.9%) had pyuria and positive urine culture (M=43.3%,
F=56.6%).
The most common bacterial pathogen isolated was E.coli
(43.3%), followed by Klebsiella (26.6%), Acinetobacter (13.3%),
Proteus (10%) and S.aureus (6.6%) as shown in Fig.1.
Work up revealed physiological jaundice to be the commonest
cause of hyperbilirubinemia.  UTIs were observed more
commonly in bottle-fed infants and infants with mixed feeds
than breast-fed infants as shown in Fig. 2. There was no
significant difference between neonates with UTI and without
UTI in respect to gestational age, body weight and total serum
bilirubin (TSB) at the time of admission.
Table 1: Distribution of neonates according to urinalysis &
urine culture results.
Pyuria No pyuria
Male 30 52
Female 47 44
Total 77 96
Pyuria present Positive  urine Negative urine
culture culture
Male 13 17
Female 17 30
Total 30 47
Fig 2. Number of neonates with UTI and their mode of
feeding.
Total
Sum of Bottle FeedSum of Mixed Sum of Breast Feed
0
2
4
6
8
10
12
14
Fig 1. Frequency of isolated bacterial pathogen in urine
culture.
E.Coli
Kleibsella
Acinobacter
Proteus
Staph. Aureus
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Table 2 shows 143 (82.6%) of neonates had jaundice reported
before or at 08 days of age and 30(17%) after 08 days. Moreover,
of 173 jaundiced babies, only 25 babies had predominantly
direct hyperbilirubinemia (14.4%) while the rest had indirect
hyperbilirubinemia (85.5%).
The renal ultrasound revealed urinary tract abnormalities in
only 2(1.15%) patients which was hydronephrosis, while grade
II parenchymal changes were shown in 13(7.5%) patients.
Discussion
The results of our study revealed that 44.5% of the jaundiced
babies had pyuria, of which 39 % were culture positive and the
most common organism isolated was E. coli. Presence of UTI
in this significant number of jaundiced patients is an important
issue and needs to be emphasized so that proper diagnosis could
be established and appropriate management be instituted.
Association of UTI with hyperbilirubinemia is not a new topic
for the researchers. It was mentioned in studies about eight
decades back and again for the last four decades it has been re-
emphasized. It has been known for long that patients with UTI
usually exhibit conjugated hyperbilirubinemia9, 10 but our study
shows contrary to this fact, almost all the babies presented with
unconjugated hyperbilirubinemia. This could probably be due
to the fact that higher levels of bacteremia could produce a
higher rate of hemolysis and, consequently increased
unconjugated bilirubin levels.
The incidence of UTI was seen to be higher in our study as
compared to the studies by Garcia & Nagar, Bilgen,
Chavalitdhamrong, Hung-Ta Chen et al, and Tariq Khudair and
Hussain (E.coli7.5%, Kleibsella8%,Acinobacter 2.9%,
Proteus14%, andS. aureus 6.5% respectively).3,9,10,11
Similar to other studies body weight and gestational age were
not associated with UTI. In contrast to the results of other
studies,12 urinary tract abnormalities were seen in only 1.15%
of neonates with UTI, this difference may be due to the smaller
number of patients with UTI.
In most of the studies, conjugated hyperbilirubinemia
predominated in babies with UTI and this was quite justified
by various mechanisms like “microcirculatory changes in the
Table 2: Distribution of neonates according to onset and
type of jaundice.
Type of  Direct Indirect
hyperbillirubenemia 25 148
Age less than 8
days of life
143Onset of jaundice
Age between 8-14
days of life
30
liver, direct effect of bacterial products and or endotoxin induced
mediators”.13 However in our study majority of the babies with
UTI had indirect hyperbilirubinemia. This could be well
explained by the fact that the bacterial burden and toxins can
cause higher rate of hemolysis and hence can lead to
unconjugated bilirubin levels14. Moreover, cholestasis can also
occur due to infection and possible low activity of the enzyme
glucuronictransferase may contribute to the high levels of
indirect bilirubin in these neonates.15,16
Routine screening for UTI in asymptomatic jaundiced babies
is still controversial. According to American Academy of
Pediatrics’ guidelines; for all newborn infants 35 or more weeks
of gestation, it is recommended that the clinicians should
perform urinalysis in the presence of increased direct bilirubin
levels or readmission for phototherapy or exchange transfusion.8
Additional laboratory evaluation for sepsis should be performed
if indicated by history and physical examination. However, in
our study, UTI in babies presented with indirect
hyperbilirubinemia. Similar findings have been seen in the
study by Lee et al.17 Therefore, we strongly suggest that urinary
tests for UTI should not only be confined to babies with
conjugated hyperbilirubinemia. People have argued against the
routine testing as more than two thirds of normal infants
especially in Asians present with jaundice during first weeks
of age and the reported incidence of UTI in jaundiced infants
varied from 1% to 11% in different countries.3, 18, 19.
Irrespective of the mechanism and type of hyperbilirubinemia,
it seems justifiable to investigate all asymptomatic babies with
jaundice for UTI. Urine analysis seems cost effective even in
resource poor settings like ours when there’s a benefit of treating
UTI versus risk of missing it.
Conclusion
Jaundice is a common presenting symptom in neonates; its
association with UTI has not been established and amplified
globally. In our study we have found that UTI may present with
pathological jaundice in neonates, so we conclude that all
neonates presenting with jaundice should be investigated for
urinary tract infections.
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Abstract
Background
This study was carried out  to  determine  frequency of  extended
spectrum beta lactamases  producing Gram negative bacilli
among clinical isolates as a result of culture of all specimens
received in POF Hospital laboratory at Wah.
Material and Methods
Three hundred and eighty five clinical isolates of Gram negative
rods from various clinical specimens in six months period from
September 2010 to Feb 2011 were included in the study. All
the isolates were processed by standard microbiological methods.
The detection of extended spectrum beta lactamase (ESBL)
production in these isolates was carried out by double disc
synergy method.
Results
Out of three hundred and eighty five isolates, ninety three
(24.2%) were ESBL producers and two hundred and ninety
two (75.8%) were non ESBL producers. Escherichia coli was
the most commonly  isolated ESBL producer followed by
Klebsiella pneumoniae.
Conclusion
ESBL producing isolates are prevalent in our setting. Infection
control measures and judicious use of extended spectrum
antibiotics are required to combat this grave situation.
Keywords
Extended spectrum beta lactamases, Gram negative bacilli,
Extended spectrum antibiotics.
Background
The world of infectious disease has become very complicated
due to antimicrobial drug resistance which is an inevitable
consequence of injudicious use of antimicrobial therapy.1
Extended spectrum beta lactam antibiotics such as third
generation cephalosporins form the major component of the
empirical antibacterial armamentarium in the most clinical
setups. In the past it was believed that cephalosporins were
relatively immune to attack by β-lactamases.2 The persistent
exposure of bacterial strains to a multitude of β-lactamas has
induced a dynamic and continuous production and mutation of
β-lactamases in these bacteria, expanding their activity even
against the third generation cephalosporins. Thus these enzymes
are called extended spectrum β-lactamases.
However, there is no consensus on the precise definition of
ESBL. A commonly used working definition is that extended-
spectrum β-lactamases are a rapidly evolving group of β-
lactamases which share the ability to hydrolyze third-generation
cephalosporins and aztreonam but are inhibited by clavulanic
acid.3
Important ESBL producing Gram negative bacilli are Escherichia
coli, Klebsiella pneumonia, Proteus mirabilis, Enterobacter
spp., Citrobacter spp., Pseudomonas aeruginosa and
Acinetobacter baumannii.4 The frequency and susceptibility
pattern of ESBL producing organisms differ significantly in
accordance with geographical locations.5 There exists  marked
hospital to hospital variability even  within a country.6 The
variable pattern of ESBL producing isolates parallels the misuse
or overuse of beta lactam drugs.7 Frequency of ESBL producing
Gram negative bacilli  is 28% in Bulgaria, 16% in Cyprus and
Romania, 12% in Portugal. 8 Studies in India showed a frequency
of 20% 9 while Ali et al 4 and Jabeen et al10 from Pakistan have
reported a frequency of 43% and 50% respectively from
Rawalpindi and Karachi. The available therapeutic options for
the treatment of ESBL producers associated infections are
limited by drug resistance conferred by ESBL producing
organisms, along with frequently observed cross resistance to
other antibiotics as well, like aminoglycosides, quinolones and
cotrimoxazole.10
Detection of ESBL production is of utmost importance both in
hospital and community isolates. The  prevalence of these
enzymes is increasing worldwide with rates varying greatly
even among hospitals in a given region.11 The  ESBL producers
 constitute a serious threat to currently available antibiotics, as
they leave behind limited therapeutic choices. The institutional
outbreaks are increasing because of selective pressure due to
excessive use of extended spectrum cephalosporins and lapses
in effective control measures. Extreme vigilance and timely
recognition of infections with ESBL producers and appropriate
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antibiotic therapy is the only answer to the current grave situation.
Frequency and susceptibility pattern varies from region to
region and time to time, so local pattern of susceptibility or
institutional antibiograms should be used to determine the
choice of drug.12 Indiscriminate use of antibiotics lead to
emergence of multidrug resistant ESBL producing Gram negative
pathogens and nosocomial outbreaks that could bring about
prolonged stay, increased mortality, expensive control efforts
and therapeutic failures.
The objective of this study is to document the frequency of
ESBL producing Gram negative bacilli in tertiary care hospital
at Wah bearing in mind that no such study had been carried out
before. This effort will limit inappropriate antimicrobial usage
and rationalize empirical therapy to avoid antibiotic selective
pressure along with improvement of infection control measures
focusing on reducing patient to patient transmission via the
inanimate environment, hospital personnel and medical
equipments, hence decrease emergence and dissemination of
antimicrobial resistance in our setup.
Materials and Methods
This descriptive study was carried out in Microbiology section
of Pakistan Ordnance Factories Hospital laboratory from
September, 2010 to February, 2011 on clinical samples received
from admitted patients as well as  patients from outdoor
departments. The specimens were inoculated on appropriate
culture medium like blood agar, MacConkey agar, chocolate
agar (sputum) and cysteine lactose electrolyte deficient agar
(urine). These were incubated at 35-37°C under aerobic
conditions for 24 hours. After overnight incubation, the agar
plates were examined for growth of bacteria and their colonial
morphology. The Gram negative rods were identified based on
Gram staining and biochemical tests.13 Antimicrobial
susceptibility tests were performed on the Muller–Hinton agar
plates with disk diffusion method as recommended by clinical
laboratory standards institute.14
Double disk synergy method was used to screen ESBL producing
isolates. After subculture of suspensions of the isolates on
Mueller-Hinton agar , an antibiotic disk containing amoxicillin-
clavulanate (20/10 µg) was placed in the centre of the plate.
Disks of 30 µg aztreonam, ceftazidime, ceftriaxone and
cefotaxime were placed at a distance of 30 mm (edge to edge)
from the central disk. Zones of inhibition around the third
generation cephalosporin disks and aztreonam were observed
after overnight incubation at 37°C. The organism reflecting
inhibition zone around one or more cephalosporins disks and
aztreonam  extended on the side nearest to amoxicillin-
clavulanate was considered to show the synergism and it was
identified as an ESBL producer.15
E. coli ATCC 25922 and K. pneumoniae ATCC 700603 were
used for quality control of the test procedure.14
The data was entered and analyzed using SPSS version 10. For
qualitative variables (ESBL producers among Gram negative
bacilli, gender, type of samples and organisms isolated)
frequencies and percentages were calculated. Mean ± SD was
presented for age.
Results
A total of three hundred and eighty five (385) isolates of Gram
negative rods were studied. Majority of isolates (n=163, 42.3%)
were isolated from urine. The other isolates were from blood
(17.7%), high vaginal swabs (11.4%), pus (10.4%), catheter
tips (6%), ear swabs (5.5%), body fluids (1.8%), endotracheal
tubes (1.6%), sputum (1.6%), tracheostomy discharge (1.3%)
and throat swabs (0.5%). The distribution of specimens is
presented in table 1.
Out of three hundred and eighty five (385) isolates, ninety three
(24.2%) were ESBL producers and two hundred and ninety
two (75.8%) were non ESBL producers. The commonest ESBL
producing organism isolated was Escherichia coli (47.3%),
followed by Klebsiella pneumoniae (24.7%), Pseudomonas
aeruginosa (8,6%) and Enterobacter aerogenes (7.5%). (Table-2)
Out of ninety three ESBL producer isolates, 54.8% were
recovered from female patients and 45.2% from male patients.
Mean age of the patients was 47.38 + 24.22 years (mean + SD).
Age distribution of different age groups which yielded ESBL
isolates is shown in Figure 1.
Thirty seven isolates (39.8%) were isolated from outdoor
patients, while the remaining (n=56, 60.2%) were from patients
admitted in different wards including General Medicine (29%),
Medical intensive care unit (9.7%), General surgery (8.6%),
Neonatal intensive care (5.4%), Paediatrics Medicine (4.3%),
Gynecology/obstetrics (2.2%) and ENT ward (1.1%). The
distribution is presented in Figure 2.
Discussion
Antibiotic resistance surveillance has a key role among all
strategies to manage antibiotic resistance as an inevitable
consequence of indiscriminate and injudicious utilization of
antimicrobial therapy. There is tremendous variability of
antimicrobial resistance in different geographic regions. This
phenomenon makes continuous surveillance of the extent and
trends of antimicrobial resistance essential for guiding effective
empiric therapy in every continent, country, city, hospital or
even health care unit. 16 This study had provided an overview
of the current situation regarding ESBL producing Gram negative
bacilli in POF hospital with a focus on their frequency. In our
study, the frequency of ESBL producer isolated among Gram
negative bacilli was 24.2%. Escherichia coli (47.3%) was the
most commonly isolated pathogen followed by Klebsiella
pneumoniae (24.7%) and Pseudomonas aeruginosa (8.6%).
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Analysis of studies over the last decade had revealed frequencies
of 40-50% of ESBL producer in different parts of Pakistan.
Shah et al had reported a frequency of 48% of ESBL producer
with E. coli as the most prevalent organism among the patients
of age group ranging from 50-60 years. ESBL producing isolates
were mostly reported in males (65.3%) compared to females
(34.7%).17 These findings were in contrast to our results which
showed increased frequency of ESBL producing isolates among
female patients as compared to males. Whereas the patients of
age group ranging from 61 to 70 years have yielded maximum
ESBL producing isolates.
In a study carried out in Karachi, 40% of Gram negative isolates
were found to be ESBL producers. ESBL positivity was detected
in 50% Enterobacter spp., 42% E. coli and 36% K. pneumoniae.
ESBLs producing Gram negative bacilli were more frequent
in nosocomial isolates and in patients at extremes of ages (under
5 years and more than 60 years).10 The later findings were
similar to our study in which majority of ESBL producers were
of hospital origin and in patients at extreme of age.
Ali et al had reported a frequency of 45% of ESBL producing
Gram negative isolates from Rawalpindi with Enterobacter
cloacae (79%) as the most prevalent organism followed by
Acinetobacter baumannii (72%) and Klebsiella oxytoca
(66.7%).18 These bacilli were different from those which were
yielded in our setup, thus reflecting variable pattern of ESBL
producing isolates.
There are studies which show changing trends in frequency of
ESBL producing Gram negative bacilli. Sattar et al reported
decreased  frequency of Gram negative bacilli which were
ESBL producers  during  four years (2003-2007).19 It was 66%
during December 2003- November 2004, 54% during December
Table 1: Frequency of different types of clinical specimens (n=385)
Specimens Frequency Percent Valid Percent Cumulative Percent
Blood 68 17.7 17.7 17.7
Tracheostomy discharge 5 1.3 1.3 19.0
Endotracheal tubes 6 1.6 1.6 20.5
Urine 163 42.3 42.3 62.9
High viganal swabs 44 11.4 11.4 74.3
Sputum 6 1.6 1.6 75.8
Catheter tips 23 6.0 6.0 81.8
Biological fluids 7 1.8 1.8 83.6
Pus 40 10.4 10.4 94.0
Throat swabs 2 0.5 0.5 94.5
Ear swabs 21 5.5 5.5 100.0
Total 385 100.0 100.0
Table 2: Frequency of  ESBL producers among Gram negative isolates (n=93)
Frequency Percent Valid Percent Cumulative Percent
Escherichia coli 44 47.3 47.3 47.3
Serratia marcescens 2 2.2 2.2 49.5
K.pneumoniae 23 24.7 24.7 74.2
Enterobactor aerogenes 7 7.5 7.5 81.7
Acinetobacter baumannii 2 2.2 2.2 83.9
Pseudomonas aeruginosa 8 8.6 8.6 92.5
Proteus mirabilis 2 2.2 2.2 94.6
Proteus vulgaris 3 3.2 3.2 97.8
Citrobacter ferundii 2 2.2 2.2 100.0
Total 93 100.0 100.0
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2004- November 2005), 57%  during December 2005- November
2006 and 47%  during December 2006- November 2007. The
study concluded a decrease trend  in the frequency of ESBL
producers but the organisms showing same resistance
pattern as ESBLs producing isolates were on rise.
The results of our study were closer to study carried out in
Lahore which revealed 35.5% of bacterial strains to be ESBL
producers. The commonest ESBL producing organisms isolated
were E. coli (44.8%), followed by K. pneumoniae (38.6%), P.
mirabilis (31.6%) and A. baumanni (7.1%).1 Similarly, study
conducted by Ullah et al to assess ESBL prevalence in
Pseudomonas aeruginosa isolated from burn patients in the
North West of Pakistan revealed 35.85% isolates to be ESBL
producer.20 The high percentage of ESBL producers reflected the
extensive and indiscriminate use of antimicrobials in our setup.
Comparison with studies which were conducted in other parts
of the world revealed that the highest isolation rate of ESBLs
producing K. pneumoniae has been reported from the Latin
America (54.4%), the Western Pacific (24.6%) and Europe
(22.6%). The frequency of ESBL producing E. coli in this area
was reported to be 8.5% , 7.9 % and 5.3% respectively. 21
Studies from India also revealed variable incidence of ESBL
producers. Roopa et al conducted study on the most prevalent
uropathogens which revealed 87.5% of E.coli and 66.7% of
K.pneumoniae to be ESBL producers.22 Earlier, Taneja et al
reported that ESBL producers could explain only 36.5% of
multi drug resistant uropathogens in their study.23 Similarly
Aladag et al conducted a study on K.pneumoniae isolated from
urinary tract infection. Among 125 isolates of K.pneumoniae,
45 strains (36%) produced ESBL.24 In our study frequencies
of 47.3% and 24.7% were found for E. coli and K. pneumoniae
respectively which were closer to the results seen in other
studies.23,24
A study in Iran reported 21% of isolates of E.coli and 12% of
K.pneumoniae to be ESBL producers. Of 150 patients who had
positive ESBLs isolates, 104 (69.3%) were outpatients and 46
(30.6%) were hospitalized.25 This finding was in contrast to our
study in which most of  ESBL producing organisms were
hospital acquired.
The frequency of 24.2% ESBL producing isolates in present
study showed slight decreased trend as compared to other
studies.
We have used the commonly employed double disk diffusion
method for detection of ESBL. Evaluation of the double disk
synergy method against strains which have been genotypically
confirmed to be ESBL producers or non producers have revealed
sensitivities of the method ranging from 79% to 97% and
specificities ranging from 94% to 100%.26, 27
Conclusions
Our study revealed E.coli followed by K.pneumoniae  as the
most frequent ESBL producing Gram negative bacilli. These
isolates were found predominantly in hospital settings, in
extremes of age and in females. To conclude, ESBL producing
isolates are prevalent in our setting.
Recommendations
Considering the grave scenario of antibiotic resistance in our
country, it is high time that clinical laboratories should detect
the ESBLs routinely and accurately and the clinician should
reformulate the antibiotic policies, so that rationalized therapy
can be instituted to avoid injudicious use of antibiotics.
The methods for detection of ESBL should be improved to
assure the possibility of interventions in time.
Significance of national public health efforts should be high
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lightened to implement surveillance, epidemiologic,
environmental health and policy making components.
Infection control measures are recommended, so that appropriate
management can be instituted and spread of these organisms
curtailed.
The use of extended spectrum cephalosporins should be limited
to cases in which other therapeutic alternatives according to
evidence-based guidelines are not possible.
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Abstract
Objective
Neonatal sepsis is a clinical syndrome of both infection and
systemic inflammatory response in the first month of life. The
microbiological spectrum and their antibacterial sensitivities
vary across different communities. We performed this study to
determine the causative pathogen and antibiotic susceptibility
of neonatal sepsis in our neonatal unit to design local neonatal
sepsis management guidelines.
Method
This descriptive cross-sectional study was undertaken at neonatal
intensive care unit of Children Hospital and Institute of Child
Health, Multan using nonprobability convenience sampling
technique from Jan-Dec 2014.All neonates (from birth till 28
days) admitted with clinical signs and symptoms suggestive of
sepsis were included in the study, excluding neonates with
congenital anomalies and history of previous antibiotics
administration. Blood cultures were drawn and processed using
standard protocols. We calculate early onset and late onset
neonatal sepsis incidence; common pathogens and their
antibacterial sensitivities associated with these neonatal sepsis.
Results
 Of 161 total patients, 107 (66%) were male and 54(44%) were
female. Early onset sepsis (EOS) was present in 98 (61%) cases
and late onset sepsis (LOS) in 63 (39%).Gram negative isolates
were 65(61%) and Gram positive were 42(39%).Among Gram
negative organisms, Pseudomonas aeruginosa was most
frequent,(n=22, 34%) and in Gram positive isolates,
Staphylococcus epidermidis was the most frequent, (n=18,
43%).The Gram positive isolates showed 100 % sensitivity to
linezolid and 100% resistance to ampicillin and Gram negative
showed 85% sensitivity topipercilliin/tazobactum and 100%
resistance to Cefotaxime.
Conclusion
Gram negative microorganisms were more common than gram
positives. Isolated bacteria showed high resistance to commonly
used antibiotics.
Key Words
Neonatal Sepsis, Earlyonsetsepsis, lateonsetSepsis, Antibiotic
susceptibility.
Background
Neonatal sepsis is a clinical syndrome of both infection and
systemic inflammatory response syndrome in the first month
of life.1If present before 3 days of life, it is early onset
sepsis(EOS) and after 3 days to 28 days of life is late onset
sepsis(LOS).2 Of the estimated 130 million annual births
worldwide, 4 million die in the first 28 days of life, and nearly
half of them on the first day.3 World Health Organization
estimates that 35% of 4 million neonatal deaths (around one
and a half million) annually are due to infection.4 Millennium
Development Goal-4 aimed to reduce under-5 mortality (U5M)
close to 30 child deaths per 1000 live births by 20155 but lacked
behind and could achieve only 48 deaths per 1000 live births
largely through interventions to lower mortality after the first
month of life and neonatal survival was not addressed properly
that’s why neonatal mortality rate (NMR) is still 44% of the
total child mortality.6
Every Newborn Action Plan(ENAP) now aiming to reduce
NMR below 10 per 1000 live births till 20356 and Pakistan is
one of its partners as it is amongst the top 8 countries with
highest neonatal mortality (55/1000 live births).7 Neonatal sepsis
is the third most important cause of neonatal mortality after
prematurity and birth asphyxia.8 Incidence of neonatal sepsis
varies from 1 to 5 cases per 1000 live births in developed
countries, but gets higher in developing countries which varies
from 49 to 170 per 1000.8
Pathogens causing neonatal infection or sepsis differ between
countries; institutions within the same country and even within
the city and so are the sensitivity pattern to commonly used
antibiotics due to local protocols.9 There is lack of local published
literature on common EOS and LOS pathogens and their
susceptibility pattern. We designed this descriptive cross sectional
study to determine common causative bacterial pathogen in
neonatal sepsis along with their susceptibility pattern to
antimicrobial drugs in neonates admitted to neonatal intensive
care unit (NICU) of children hospital complex Multan, Punjab,
Pakistan.
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Material and Methods
This descriptive cross-sectional study was conducted at neonatal
intensive care unit (NICU) of Children Hospital and Institute
of Child Health Multan from 1st January 2014 to 31st December
2014. Our NICU is 20 bedded including 8 incubators and 8
ventilators. Annual neonatal admissions through outpatient and
emergency departments are 6000 and 646 shifted to NICU
where annual deaths are 281. First line antibiotics are Ceftazidime
and Amikacin.
A total of 256 neonates of either gender (from birth till 28 days)
admitted with clinical signs and symptoms suggestive of sepsis
i.e fever, grunting, cyanosis, respiratory distress, reluctance to
feed, vomiting, lethargy and weak cry, were included in the
study after informed consent from their parents. We performed
non probability convenience sampling. Blood culture was sent
in these cases. A single specimen of 2 to 3 ml of blood was
collected from peripheral vein keeping all aseptic measures.
Neonates who received antibiotics prior to admission or had
chromosomal or congenital anomalies were excluded from the
study. Neonates presenting before 3 days of life were labeled
as early onset sepsis and after 3 days to 28 days of life were as
late onset sepsis.2
161 neonates of either gender were studied after excluding 95
due to either congenital anomalies or prior antibiotic intake in
this illness. Detailed history and complete physical examination
was carried out on each patient. Blood samples were inoculated
on standardized media and incubated at 37oC for 3 days. Sub-
cultures were then made on blood agar, chocolate agar and
McConkey agar. The colonies isolated, were identified by their
colonial morphology, gram’s stain and conventional biochemical
and serological tests. Antibiotic susceptibility pattern of the
isolates was studied by using conventional disc diffusion
technique. Antibiotics relating to culture sensitivity were
categorized and analyzed according to their mode of action
into groups like Penicillin, Aminoglycosides, Cephalosporins,
Fluoroquinolones, Vancomycin, Carbapenems and Linezolid.
Other investigations including relevant hematological,
biochemical and radiological were also performed. Data was
entered, analyzed by SPSS version 19. Descriptive statistics
were used to describe the frequency and percentages of different
microorganisms in culture positive patients.
Result
Of 161 total patients, 107 (66%) were male and 54(44%) were
female. EOS was present in 98 (61%) cases whereas LOS was
found in 63(39%) cases. No growth found in 54(33.5%),
42(26%) were Gram positive and 65(40%) were Gram
negative.(table1).
Frequent organisms found were Pseudomonas aeruginosa, 22
(13.8%), Staphylococcus epidermidis, 18(11.4%), and
Escherichia coli (E coli), 15(9.4%). Pseudomonas aeruginosa
was most frequent Gram negative organism 22 (33.8%), (table
2), and Staphylococcus epidermidis was the most frequent gram
positive 18 (42.8%). (table 3).
Gram positive isolates had a high resistance (100%) to Ampicillin
and Cefotaxime except Staphylococcus Epidermidis and
Staphylococcus aureus which showed 85% to Ampicillinand
Cefotaxime respectively. The resistance of Gram negative
microorganism to Amikacin was also found very high ranging
from 50% by Salmonella to 100% by Proteus and Klebsiella.
In Gram negative isolates enterobacter, Pseudomonas, klebsiella
and Proteus were 100% sensitive to Piperacillin/Tazobactam
while Escherichia coli and Salmonella showed 50 % sensitivity.
Salmonella, Klebsiella and Proteus were 100% sensitive to
Cefoperazone/Salbactem while Escherichiacoli, Pseudomonas
and Enterobacter showed 90%, 65% and 30% respectively.
(table 4).
Table 1: Bacterial isolates responsible for neonatal sepsis
in NICU of Children Hospital, Multan
Bacterial Isolates Frequency(n) Percentage (%)
No growth 54 34
Gram Negative 65 40
Gram Positive 42 26
TOTAL 161 100
Table 2: Gram negative isolates responsible for neonatal
sepsis in NICU of Children Hospital, Multan
Gram negative Isolates Frequency(n) Percentage (%)
Pseudomonas aeuriginosa 22 34
Escherichia coli 15 23
Enterobacter 8 12
klebsiella 7 11
Salmonella 7 11
Proteus 6 9
Total 65 100
Table 3: Gram positive isolates responsible for neonatal
sepsis
Gram negative Isolates Frequency(n) Percentage (%)
Staph epidermidis 18 42
Staph aureus 12 29
Staph saprophyticus 12 29
Total 42 100
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All the isolated Gram positive bacteria were 100 % sensitive
to linezolid. Staphylococcus aureus and Staphylococcus
epidermidis developed 75% and 69% resistance to Imepenem
respectively, while the sensitivity of Staphylococcuss
aprophyticus is still 100 % to Imepenem and 50 % to Meropenem.
Staphylococcuss aprophyticus also showed 100% sensitivity
to Piperacillin Tazobactum while Staphylococcus aureus and
Staphylococcus epidermidis showed 50% sensitivity. (table 5)
Discussion
Estimated 4 million neonatal deaths occur worldwide and
developing countries are responsible for 99% of these.5
Worldwide, infections (sepsis, pneumonia, diarrhea and tetanus)
are third most important cause of mortality preceded by
prematurity and birth asphyxia.6 NMR (neonatal mortality rate)
in Pakistan is 55/1000 live births and infections are 2nd most
common cause after prematurity.10
Studies state that male neonates are more susceptible to neonatal
sepsis compared to females due to reasons not completely
understood. Our study also depicted that male are more prone
to sepsis than female gender with a ratio of 1.9:1. This finding
is consistent with certain studies where male to female ratio
was around 2:1.8, 9, 11, 12
Although blood culture is gold standard for diagnosis of sepsis
but it has limited sensitivity and specificity and yields positive
result in only 10-60% of cases.13 Our study had culture positivity
rate of 66.5%, which is around top of this range and if we
compare to others in Pakistan i.e. 62.8% by Rahman et al,14
32% by Ahmad et al15 and17.1% by Goheer et al.16
Late onset sepsis (LOS) is more common as compare to early
onset sepsis (EOS) in developed countries17, 18 which is opposite
in developing countries where EOS is more than LOS and we
observed similar results in our study where EOS is 61% while
LOS is 39% and Sheikh et al, Ahmad et al and Waseem et al
reported coinciding results.10, 15, 19
Table 4:  Sensitivity of Gram negative microorganisms to commonly used antibiotics
Antibiotics
Ampicillin - 0 - - 0 -
Amikacin 35 20 33 0 0 50
Ceftazidime 0 0 0 0 0 0
Pipercillin/ Tazobactum 100 40 100 100 100 50
Cefoperazone/Salbactem 70 10 35 100 100 100
Imepenem 70 60 41 100 100 50
Meropenem 50 10 35 100 50 100
Ciprofloxacin 65 10 17 50 50 50
Enterobacter Escherichia. Coli Pseudomonas Klebsiella Proteus Salmonella
aeuriginosa
Sensitivity
Antibiotics
Ampicillin 0 15 0
Amikacin 25 33 50
Ceftazidime 15 0 0
Vancomycin 25 69 50
Piperacillin/ Tazobactam 50 50 100
Cefoperazone/Salbactem 50 10 50
Imepenum 25 69 100
Meropenum 25 15 50
Ciprofloxacin 50 41 50
linezolid 100 100 100
Table 5:  Sensitivity of Gram positive microorganisms to commonly used antibiotics
Sensitivity of  Gram positive microorganisms to commonly used antibiotics
Sensitivity of
Staphylococcus
epidermidis
%
Sensitivity of
Staphylococcus
saprophyticus
%
Sensitivity of
Staphylococcus
aureus
%
Gram negative bacteria were more common than gram-positive.
Similar results are found by Muhammad et al, sheikh et al,
Waseem et al and Basheer et al.9, 11, 19, 20 Coagulase Negative
Staphylococcus (CONS) and Group B Streptococcus are common
Gram positive bacteria found in western countries but in our
setup Staphylococcus aureus and CONS are common whereas
Group B streptococcus is very uncommon.8, 18, 21 Among Gram
negative bacteria E coli is the commonest followed by
Pseudomonas, Klebsiella and Acinetobacter but we found in
our study Pseudomonas on top followed by E coli.9, 11, 22
Bacterial resistance to commonly used antibiotics in our settings
such as Ampicillin and Cefotaxime was found quite high ranging
between 85-100%. The study by sheikh et al found almost
similar resistance pattern.11 Klebsiella and Proteus showed
100% resistance to Amikacin while Salmonella and
Staphylococcuss aprophyticus showed 50%. Arham et al found
Klebsiella 40% sensitive to Amikacin and Pseudomonas 83%
but in our study Pseudomonas was 33% resistant to Amikacin.7
Resistance against quinolones, once found low compared to
commonly used antibiotics, is emerging due to their
indiscriminate use. Shaw et al found Staphylococcus aureus,
Streptococcus and Enterobacteriaceae to be highly resistant to
Ciprofloxacin,20 and in our study resistance to Ciprofloxacin
ranged between 35 to 90 % where Enterobacter is at 35% and
E.coli at 90%. Imepenem is described by Waseem et al and
Shaw et al as 100% sensitive to Staphylococcus aureus,
Acinetobacter, Klebsiella, E.coli and Enterobacteriaceae18, 20
but in our study S. aureus and S. epidermidis showed 75% and
69 % resistance to Imepenem while Staphlococcus saprophyticus,
klebsiella and Proteus showed 100% sensitivity, Muhammad
et al demonstrated high resistance of Imepenem against
Staphylococcus aureus, but no resistance against Acinetobacter,
Klebsiella and Enterobacter.9 Linezolid found to be 100%
sensitive to all gram positive isolates in our study
and also by Arham et al, Li et al and Sheikh et al.7, 8, 11
Conclusion
The present study revealed that Staph epidermidis is the most
common Gram positive bacterium and Pseudomonas is the most
common Gram negative bacterium causing neonatal sepsis. All
the bacterial isolates are highly resistant to commonly used
antibiotics such as Ampicillin, Cefotaxime and Amikacin. Resistance
is also emerging against Vancomycin and Ciprofloxacin. Gram
positive organisms were highly sensitive to linzeolid.
Limitation of Study
Our study was conducted in a single neonatal unit so the
information obtained about the pattern of microorganisms and
their antibiotic sensitivities is specific to the unit and probably
cannot be generalized to all the neonatal units in the city.
Moreover limited number of antibiotics was checked due to
availability of limited kits.
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Abstract
Introduction
During the past two decades, the incidence of candidemia has
doubled and Candida spp. currently ranks in top blood stream
pathogen in developed countries. Given the need to ensure
appropriate and timely antifungal therapy, there is need to
identify these patients as early as possible and therefore a risk
stratification for candidemia is imperative. We aim to identify
the risk factors of candidemia in patients admitted at our tertiary
care center.
Methods
A retrospective case control study  were conducted on adult
patients (15 years. or more) admitted to Aga Khan University
Hospital between 2009 and 2013 who developed candidemia
(cases)or bacteremia (controls) after 48 hours of admission.
Results
A total of 300 patients were enrolled in study (150 cases i.e.
candidemia and 150 control i.e. bacteremia). The gender
frequency was identical for cases (n=56, 65% males) and
controls (n= 55,64 % males). Mean age in year was also similar
for cases (56± 17) and controls (55± 18, p = 0.5). Non albican
candida spp. are predominantly isolated from blood cultures
as compared to Candida albican. Patients who had invasive
devices like central lines, urinary catheter, endotracheal tube,
nasogastric tube especially central lines (Odd ratio 1.72, CI:
0.98-3.02) and patients who had candida colonization (OR8.50,
C.I: 3.76-19.23) were more likely to have candidemia than
bacteremia.
Conclusion
Risk factors for candidemia include, the presence of invasive
devices especially central lines and isolation of candida from
other body sites were most predictive of candidemia. These
results can be used to help identify patients most likely to
benefit from empiric antifungal therapy.
Key words
candidemia, risk factors, candida colonization, invasive devices
Introduction
Candida species are one of the most frequent pathogens isolated
in bloodstream infections1 and are associated with significant
morbidity and mortality. Blood stream infections (BSI) caused
by various Candida species have been reported from many
countries worldwide and are a significant cause of morbidity,
prolonged hospital stay and mortality in hospitalized
patients.2,3,4,5,6 During the past two decades, the incidence of
candidemia has been doubled and candida now currently ranks
as the fourth and the seventh most common bloodstream
pathogen in North American and Europe respectively7,8
The situation in Asia regarding the incidence of candidemia is
however, not very clear due to lack of multicenter studies. A
13-year long study on candidemia from a tertiary care hospital
in Thailand showed a prevalence of 6.14% for Candida species
among blood culture isolates.9 Similarly the prevalence of
candidemia was between 6 % to 8% in different parts of India
as reported by S Giri et al.10 In Taiwan, candidemia was the
second most common cause of health care-associated
bloodstream infections (HA-BSIs), following after bacteremia
by Staphylococcus species and Acinetobacter baumannii and
Escherichia coli.11
Candidemia is often present in patient with underlying co
morbidities and hence risk factors for candidemia include
exposure to antibiotics, steroids, chemotherapy and total parental
nutrition (TPN),or the presence of renal failure, neutropenia,
invasive devices and candiduria.3,9,10
Unfortunately while delaying antifungal therapy in patients is
often associated with poor outcomes such as prolonged hospital
stay, morbidity and mortality,6,12,13,14 the presentation of
candidemia is non-specific and difficult to differentiate from
bacteremia. This makes early identification of these patients
paramount. While diagnostic biomarkers (β-D-glucan) have
promise, blood cultures still remain the gold standard for
diagnosis and take 24 to 72 hours for growth.
Given the need to ensure appropriate and timely antifungal
therapy, there is need to identify these patients as early as
possible. We therefore attempted to design a predictive model
which would help differentiate bacteremia from candidemia
early, allowing judicious initiation of early empiric anti-fungal
therapy.
Materials and Methods
We conducted a retrospective case control study at a tertiary
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care teaching hospital in Karachi Pakistan. The Aga Khan
University Hospital is a 700-bedded tertiary care referral hospital
catering to a wide variety of patients from the region. The
facility includes several ICUs and an active stem-cell and renal
transplant service.
All patients above the age of 15 years who were admitted in
hospital between January 2009 and December 2013 and had
candidemia or bacteremia either on admission or during course
of hospitalization were included in study. Cases with mixed
blood stream infection and those with previous episodes of
candidemia and bacteremia in last one month were excluded
from study. Approval for the study was obtained from Human
Ethics Review Committee, AKUH prior to initiation of data
collection.
Medical records were reviewed and Information regarding
patient demographics i.e. age and sex and risk factors like
underlying  co-morbid conditions (bone marrow transplantation,
diabetes mellitus, chronic renal disease, chronic liver diseases)
was collected as well as details regarding current treatment
such as use of any antibiotics in previous 2 weeks, corticosteroids
in last 30 days, chemotherapy in previous 30 days, presence of
any invasive device (central venous pressure  line(CVP),
peripherally inserted central line( PICC line ),urinary catheter,
endotracheal tube), neutropenia, prior surgery within 30 days,
candida isolated from any other site like urine, sputum , tracheal
aspirate and administration of total parental nutrition  at time
of diagnosis were recorded.
Definitions
Candidemia was defined as the isolation of a candida species
from at least one blood culture and bacteremia was defined as
the isolation of pathogenic bacteria from at least one blood
culture at time of admission or during stay in hospital. In cases
where usual blood contaminants were isolated (e.g. coagulase
negative staphylococcus, corynebacterium species), patients
were included only if they had multiple culture positive for the
same organism. Neutropenia was defined as a neutrophil count
<500 neutrophils/mm. Invasive devices include central line
(like central venous pressure line, peripherally inserted central
line), urinary catheter, endotracheal tube, present at time of
positive culture or removed within two days. Candida
colonization is taken as isolation of candida species from body
sites other than blood like urine, respiratory secretions, wound.
Prior surgery within 30 days, chemotherapy within 30 days,
use of antibiotics for last 15 days and steroids (any dose) for
30 days were considered as significant risk factors. Total parental
nutrition at time of positive blood culture or within 48 hrs was
considered significant.
Data Analysis
Descriptive analysis was carried out for demographic and
clinical characteristics and results are presented as mean±SD
for quantitative variables and numbers (percentages) for
qualitative variables. To analyze the clinical characteristics of
hospitalized patients with candidemia compared to bacteremia,
the categorical variables were evaluated using the chisquare
whereas the means were compared using the Student’s t-test.
All variables with p-value less than 0.25 on univariate analysis
were then included in multivariable analysis. A stepwise
procedure was used to select the variable with a value of p<0.25
as the inclusion criteria for best fitted multivariable model. P
value less than 0.05 was considered to be statistically significant.
The SPSS software(ver. 19) is used to perform all the statistical
analysis.
Results
A total of 300 patients were enrolled in study (150 cases of
candidemia and 150 with bacteremia). Demographic and clinical
characteristics are shown in table1. Both groups were identical
in gender (65% males with candidemia vs. 64 % males with
bacteremia) and age (mean age of 56 +/- 17 vs. 55 +/- 18 for
the candidemia and bacteremia group respectively).
Non albican candida species are predominantly isolated from
blood cultures as compared to Candida Albicans. The distribution
of bacterial and candida species among patients selected for
this study is shown in Table. 2
Candida species were Candida albican (14%), Candida
parapsilosis ( 14), Candida tropicalis (14%), Candida glabrata
(5%) and Candida krusei (1%). Other candida species were
Candida lusitaniae and Candida guilliermondii. Among bacterial
species, E. coli was most commonly isolated in blood (30%).
Other bacterial species isolated were Acinetobacter (8%),
Staphylococcus aureus (17%), Coagulase-negative staphylococci
(8%) and Klebsiella pneumonia (9 %). Bacterial species with
l o w  f r e q u e n c y  w e r e  E n t e ro b a c t e r ,  P ro t e u s ,
Stenotrophomonasmaltophilia, Burkhoderiacepacia and
Micrococcus.
No clear risk factors were found differentiating candidemia
from bacteremia such as presence of underlying medical
illnesses, prior exposure to antibiotics, use of steroids, TPN,
prior surgery and chemotherapy. However, patient with chronic
liver disease were more likely to have bacteremia compared
to Candidemia (OR = 0.43;95% CI: 0.21-0.88).
More patients with candidemia had invasive devices (p value
0.001). Among invasive devices, central lines were more
common as compared to other devices (foley catheter ,
endotracheal tubes, nasogastric tube) in patients with Candidemia.
More than half patients with Candidemia (60%)
have two or more devices at time of positive culture.
Isolation of candida species from other body site culture like
urine, sputum was also common in patients with Candidemia.
Invasive device (OR = 1.72;95% CI: 0.98-3.02) and candida
isolated from other body site like urinary (OR = 8.50;95% CI:
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3.76-19.23) were found to be stronger predictors for candidemia.
Refer to Table 3 and Table 4.
Discussion
Our study found the presence of invasive devices like central
lines and isolation of candida species from body sites other
than blood were significant risk factors for developing
candidemia and there was a predominance of non albican
candida species isolated from the blood.
Among all invasive devices, presence of central venous catheter
was found to be significant risk factor for candidemia in our
study. This is in accordance with previous studies which also
identify central catheter as an important  predisposing factor
for invasive candidiasis.3,10,15,16,17,18
Candida is known to form biofilm on medical devices which
provide a nidus for infection and presence of biofilm make
candida species relatively resistant for antifungal therapy as
well. Removal of invasive device is sometimes necessary for
management of candida blood stream infection.
Majority of candidemic patients in current study also had
candida isolated from other body sites especially urine.  This
confirms the relationship between colonization by candida
species (particularly multifocal colonization) and the increased
risk of invasive candida infection.19,20,21,22 A study from Turkey
also found candiduria as an independent risk factor for
candidemia.23 Candida species are part of endogenous flora
colonize mucocutaneous surfaces. Candida colonization is one
of pre-requisites for invasive candidiasis, which in the presence
Table 1: Demographic and clinical characteristics
of hospitalized patients with candidemia and
bacteremia.
Bacteremia Candidemia
( n=150)(%) (n=150)(%)
Age( years) 54.8 ± 18.2 56.05 ± 16.9
Gender
Male 92(63.9) 95(65.1)
Female 52(36.1) 51(34.9)
Type of Malignancy
Solid organ 25(61) 26(55.3)
Hematological 16(39) 21(44.7)
Diabetes Mellitus 47(31.5) 55(37.7)
Chronic liver disease 31(20.8) 19(12.8)
Chronic kidney disease 22(14.8) 29(19.3)
Bone marrow transplant 0 1(0.7)
Hemodialysis 20(13.4) 17(11.3)
Previous Antibioticstherapya 76(52.8) 100(66.7)
Steroids use b 42(29.2) 38(25.3)
Chemotherapyc 23(16) 21(14)
Invasive devicesd 91(62.8) 120(80)
Neutropeniae 13(9.6) 20(13.3)
Total parental nutritionf 19(13.2) 15(10)
Prior surgeryg 45(31.7) 41(27.3)
Candida species isolated
from other body  siteh 8(5.8) 51(34)
a. Exposure to antibiotics for last 15 days , b. Patient receiving   steroids for
last 30 days c. Chemotherapy for last 30 days ,d .Presence of invasive devices
like central venous line , foley’s catheter, endotracheal tube, e . Neutrophils
count <500 neutrophils/mm, f. Total parental nutrition at time of diagnosis, g.
Any surgery within 30 days , h. isolation of candida from other body site like
 urine, sputum, tracheal aspirates , wounds
Table 2:    Microbiological spectrum in patients with
candidemia and bacteremia
Microorganisms    Candidemia
n(%)
Candida Albican 42(14)
Candida parapsilosis 43(14.3)
Candida tropicalis 41(13.6)
Candida glabrata 15(5)
Candida krusei 3(1)
Candida lusitaniae 2(0.7)
Candida guilliermondii 2(0.7)
Microorganisms Bacteremia
n(%)
E coli 53(29.7)
Staphylococcus aureus 30(16.8)
Coagulase-negative
staphylococci 5(8.4)
Acinetobacterspecies 15(8.4)
Klebsiellapneumoniae 16(8.9)
Enterococcus 10(5.6)
Pseudomonas aeruginosa 7(4.6)
Streptococcus group D 8(5.3)
other bacteriaa 23(15.3)
a. Other bacteria included Enterobacter, Proteus, Stenotrophomonas
maltophilia, Burkhoderia cepacia and Micrococcus
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Table 3: univariate analysis of risk factors  for candidemia
Bacteremia Candidemia Odd ratio[95% CI] p value
n=150 n=150
Type of Malignancy
Hematological 16(39) 21(44.7) 1.0
Solid organ 25(61) 26(55.3) 0.79[0.33-1.85] 0.59
Diabetes Mellitus
No 102(68.5) 91(62.3) 1.0
Yes 47(31.5) 55(37.7) 1.31[0.81-2.12] 0.26
Chronic liver disease
No 118(79.2) 130(87.2) 1.0
Yes 31(20.8) 19(12.8) 1.79[0.96-3.35] 0.06
Chronic kidney disease
No 127(85.2) 121(80.7) 1.0
Yes 22(14.8) 29(19.3) 1.38[0.75-2.54] 0.29
Hemodialysis
No 129(86.6) 133(88.7) 1.0
Yes 20(13.4) 17(11.3) 0.82[0.41-1.64] 0.58
Antibioticsa
No 68(47.2) 50(33.3) 1.0
Yes 76(52.8) 100(66.7) 1.78[1.11-2.86] 0.01
Steroidsb
No 102(70.8) 112(74.7) 1.0
Yes 42(29.2) 38(25.3) 0.82[0.49-1.37] 0.46
Chemotherapyc
No 121(84) 129(86) 1.0
Yes 23(16) 21(14) 0.85[0.45-1.62] 0.63
Invasive deviced
No 54(37.2) 30(20) 1.0
Yes 91(62.8) 120(80) 2.37[1.40-4.00] 0 . 0 0 1
Neutropeniae
No 123(90.4) 130(86.7) 1.0
Yes 13(9.6) 20(13.3) 1.45[0.69-3.05] 0.32
Total parental nutritionf
No 125(86.8) 135(90) 1.0
Yes 19(13.2) 15(10) 0.73[0.35-1.50] 0.39
Prior surgeryg
No 97(68.3) 109(72.7) 1.0
Yes 45(31.7) 41(27.3) 0.81[0.49-1.34] 0.41
Candida isolated from other body  siteh
No 130(94.2) 99(66) 1.0
Yes 8(5.8) 51(34) 8.37[3.80-18.44] <0.001
a. Exposure to antibiotics for last 15 days, b. Patient receiving  any steroids for  last 30 days, c. Chemotherapy for last 30 days, d. Presence of invasive devices
like central venous line , foley’s catheter, endotracheal tube at time of diagnosis, e. Neutrophils count <500 neutrophils/mm, f. Total parental nutrition at time
of diagnosis, g. Any surgery within 30 days, h. isolation of candida from other body site like urine, sputum, tracheal aspirates, wounds.
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of certain risk factors like  immunosuppressive state, neutropenia,
surgery, antacid therapy, invasive devices, prolonged antibiotic
use, can lead to invasion of muco -cutaneous barrier and
haematogenous spread. Candida colonization is therefore an
important factor to consider for empirical antifungal therapy
in high risk population.24,19
Our study also found a predominance of non albican candida
species of which Candida parapsilosis and Candida tropicalis
were most common species isolated. Old age, severe
immunosuppression or illness, prior antifungal therapy, exposure
to broad spectrum antibacterial agents and presence of central
lines contribute to increased incidence of candidemia caused
by non albican species of candida.1,16 Majority of our candidemic
patients were older than 50 years of age, had malignancy and
DM, prior exposure to antibiotics  and invasive devices, which
explain the preponderance  of non albican candida species in
current study. Candida parapsilosis is found on skin surfaces
and has ability to form biofilms on catheter and other implanted
devices. It can easily be spread by hand carriage and it persists
in hospital environment. Candida parapsilosis has been
increasingly implemented as a cause of candidemia after
placement of venous catheter. As most of our patient has central
lines, this can be the possible reasons of candida parapsilosis
being isolated as dominant species.
The distribution of candida species causing candidemia is
different in different geographical areas. C.albicans is
predominant species in North and central Europe and the USA.
On the contrary   non albicans candida species is more frequently
isolated  in Asia , South Europe and South America.25
Data from India also has relatively higher incidence of non
albican candida species with higher frequency of C. tropicalis
and C. parapsilosis. A recent study from Middle East also found
predominance of non albican Candidemia but species distribution
is different. It found high proportion of C. glabrata followed
by C. tropicalis and C. parapsilosis.26 Data from Pakistan on
invasive candidiasis and candidemia is limited. Other studies
from Pakistan also found non albican candida species to be
more common in patients with invasive candidiasis with a high
prevalence of C. tropicalis and C. parapsilosis.
Most common risk factors for candidemia like DM, neutropenia,
prior exposure to antibiotic and chemotherapy, prolonged use
of steroid were not able to reach statistical significance between
two groups in our studies. This study was done in single institutes
and had small sample size, which could be the possible reason
of above findings. There is a need of multi centre studies to
identify the risk factors for candidemia.
Conclusion
Presence of invasive devices and isolation of candida from
different body sites were important independent risk factors
for candidemia and can be consider to start early empirical
antifungal therapy in suspected cases of blood stream infections.
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